Activist Investor Strategies

Starboard's recent stake in Pfizer raises questions about their activist approach, especially given its less than 1% position compared to the average 6% for activist investors. Despite past successes, the current market climate, with only 11% of activist campaigns succeeding this year, suggests that investors are less inclined to challenge management. The discussion highlights the challenges of making a significant impact in companies with massive market caps and the need for compelling arguments in lieu of large stakes.